SCHEMBL4563936

SCHEMBL4563936

CCCCCc1cnnc(N2CCNCC2)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.37
▸ HRH4 Q9H3N8 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CETP P11597 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CASP4 P49662 1/20 0.36
▸ CASP5 P51878 1/20 0.36
▸ BPTF Q12830 1/20 0.35
▸ IKBKB O14920 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7363690 0.78 AOC3 (0.54) HTR2CHRH4HTR2AAOC3
SCHEMBL5658514 0.72 CHRNB2 (0.56) —
SCHEMBL1581409 0.71 BPTF (0.50) HTR2CHRH4KDM4EALDH1A1CYP1A2
SCHEMBL27471129 0.71 CHRNB2 (0.54) —
SCHEMBL27455974 0.71 CHRNB2 (0.54) —
SCHEMBL17110827 0.70 TGFBR1 (0.55) CETP
SCHEMBL5717512 0.70 S1PR1 (0.56) HTR2CHRH4KDM4EALDH1A1CYP3A4
SCHEMBL18790715 0.69 CHRNB2 (0.53) HTR2CHRH4KDM4EMEN1ALDH1A1
SCHEMBL14982162 0.69 ADRB1 (0.51) HTR2CHTR1AHTR2A
SCHEMBL177143 0.69 S1PR1 (0.58) HTR2CKDM4EALDH1A1CYP3A4HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121630-B1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2012-08-01 — — EP disclosed
EP-2121630-A1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS Janssen Pharmaceutica, N.V. (BE) 2009-11-25 — — EP disclosed
WO-2008098892-A1 FAST DISSOCIATING DOPAMINE 2 RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-21 — — WO disclosed
Send feedback